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Abstract The objective of this historical cohort study
was to compare soft tissue reactions in adults after bone-
anchored hearing implant (BAHI) surgery when the per-
cutaneous implant is placed inside or outside the line of
incision. All adult patients who received a percutaneous
BAHI between 1 January 2010 and 31 January 2014 in our
tertiary referral centre were identified. Patients were
selected if operated by two surgeons, who perform the
same standardised linear incision technique with one of
them placing the implant outside the incision while the
other prefers placement inside the line of incision. A total
of 202 patients and 211 implants were included in the case
analysis. The results showed the registration of a soft tissue
reaction Holgers C1 in 47 implants (49.0 %) placed out-
side the incision compared to 70 implants (60.9 %) which
were placed inside the line of incision. An adverse soft
tissue reaction, Holgers C2, was noticed in 17 implants
(17.7 %), respectively, 20 implants (17.4 %). No signifi-
cant differences were found between the two groups for
both the presence of soft tissue reactions Holgers C1
(p = 0.322) and a Holgers score C2 (p = 0.951). During
the follow-up three implants were lost (1.4 %) and in 18 of
211 implants one or multiple revisions were performed
(8.5 %). In conclusion, this study did not show any dif-
ferences in the presence of postsurgical (adverse) soft tis-
sue reactions between placement of the percutaneous
BAHI inside or outside the line of incision.
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Introduction
Since Tjellstro¨m introduced the percutaneous bone-an-
chored hearing implant (BAHI) for bone conduction
hearing in 1977; two hundred thousand patients have
already benefited from this hearing rehabilitation option. A
bone conduction device (BCD) is a successful treatment for
patients with both conductive and mixed hearing loss [1, 2]
and single-sided deafness [3–6]. The procedure for
implantation of osseointegrated implants is safe with a lack
of major complications [7, 8]. Nevertheless, adverse soft
tissue reactions around the titanium skin-penetrating
implant are still a frequent problem, leading to discomfort
for the patient and increased visits to the outpatient clinic.
A small percentage of these patients will suffer from
recurrent soft tissue problems, soft tissue overgrowth or
even implant loss [7–11]. The classification proposed by
Holgers et al. in 1988 is the most commonly used grading
system for these postsurgical skin reactions [9].
Over the years there have been various surgical tech-
niques used for bone-anchored hearing implantation to
prevent and minimise skin problems postoperatively, like
the free retro-auricular full-thickness skin graft, pedicled
grafts, dermatome technique and the linear incision tech-
nique [12, 13]. The linear incision technique has become
most popular because of its procedural simplicity and
association with less skin complications compared to the
other techniques [13, 14]. This technique has become even
more popular nowadays with so-called soft tissue preser-
vation, in which after the linear incision no reduction of
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subcutaneous tissue is performed. The remaining item to
address is the implant placement when using the linear
incision technique, i.e. the implant inside the line of inci-
sion or the implant outside the line of incision (Fig. 1). It is
suggested that when placing the implant outside of the
incision, it would be surrounded by scarcely traumatised
skin, reducing the inflammatory reaction occurring around
it and leading to less skin complications [15].
The aim of the current study is to identify if there is a
difference in postsurgical soft tissue reactions, as classified
by the Holgers grading system, in adults when the percu-




For this cohort study, all adult patients (aged 18 years or
older) who received any type of percutaneous BAHI at our
clinic between 1 January 2010 and 31 January 2014 were
identified from our Bone Implant database. Patients oper-
ated by two surgeons, A and B, were selected. Both sur-
geons use the same standardised linear incision technique;
they were trained and work in the same centre. Surgeon A
places the implant outside the line of incision on a con-
sistent basis, while the other surgeon B consistently uses
the technique with placement of the implant inside the line
of incision.
Eligibility criteria were: one staged procedure with tis-
sue reduction, initial placement of the implant (no previous
implant loss or removal) and availability of the medical
record including at least one postoperative visit at our
outpatient clinic.
Surgical techniques and post-surgery protocol
In the selected study period the simplified linear incision
technique with subcutaneous soft tissue reduction was
consistently used [14]. In this procedure, a longitudinal
incision of approximately 30 mm is made with the optimal
site of implantation being approximately 50 to 55 mm
posterosuperiorly to the ear canal. The next step is the
exposure and mobilisation of the periosteum after sharp
dissection of the subcutaneous tissue. Subsequently, the
implant is placed and there will be resection of subcuta-
neous tissue over an area of approximately 2 cm around the
incision. The remaining periosteum will be removed. In the
final step of the surgical procedure, surgeon A punches the
skin next to the incision while surgeon B punches the skin
in the line of incision, consequently placing the implant
outside or inside the line of incision, respectively .
The first postoperative visit was a week after surgery,
when the healing cap and gauze with antibiotic ointment
were removed, followed by an inspection of the incision.
Fig. 1 a Linear incision
technique with placement of the
percutaneous abutment outside
the line of incision. b Linear
incision technique with
placement of the percutaneous
abutment inside the line of
incision
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All patients received topical therapy with hydrocortison/
oxytetracycline/polymyxine B for 2 weeks during the first
postoperative visit. This visit was followed by an
appointment for fitting of the sound processor after
3–6 weeks. Further follow-up was in general after 3 and
after 12 months. Extra visits could be initiated by physi-
cians or patients depending on arising problems or indi-
vidual needs. In addition, some patients visited the
outpatient clinic more often because they participated in
clinical trials [16, 17]. At each visit, there was registration
of the degree of skin reaction, using the Holgers grading
system, and therapeutic intervention if applicable [9].
Case analysis
Data were obtained from our Bone Implant database and
patients medical charts. Information about incision tech-
nique, surgeon and implant type was collected. Unless
otherwise described in the operative report, it was regis-
tered that surgeon A placed the implant outside the incision
line and surgeon B placed the implant inside the line of
incision.
All follow-up visits by one of our physicians, residents
or specialised nurses were included in the analysis; con-
sultation by telephone was not included. The notes from
the physical examination were used to determine the
presence and timing of a soft tissue reaction. A Holgers
classification 2 or higher was registered as an adverse soft
tissue reaction and a Holgers classification of 1 or higher
was classified as a soft tissue reaction. The reason for this
distinction was because of the clinical consequences of the
adverse soft tissue reaction, namely an indication for (lo-
cal) treatment. Additionally, if the Holgers notation was
missing but there was notation of any redness, swelling,
moistness and/or granulation around the titanium skin-
penetrating implant in the medical record, this was still
interpreted as presence of a soft tissue reaction. A soft
tissue reaction was considered not present in case of a
Holgers score 0 or no notation of inflammation of the skin
in the notes of the physical examination. A lack of
description about the tissue surrounding the implant in the
notes of a follow-up contact was considered as missing
data.
Therapeutic interventions for skin problems were
recorded per visit. Conforming to the general protocol in
our hospital, all patients received topical therapy with
hydrocortison/oxytetracycline/polymyxine B during the
first weeks post-surgery. This topical therapy was therefore
not considered as a therapeutic intervention in our study.
Alternative therapeutic interventions were distinguished:
topical antibiotic ointment, healing cap replacement and
revision surgery (change of the abutment and/or soft tissue
revision). Implant loss was registered as well.
Finally, the background characteristics mental retarda-
tion, dermatological disease and diabetes mellitus were
registered, because recent studies focus on identification of
these comorbidities as possible risk factors in the context of
soft tissue reactions after BAHI surgery [7, 18–20]. If there
were no notes for these conditions in the medical chart or
any correspondence within the chart of the patient, this
comorbidity factor was considered absent. End of the fol-
low-up was defined as the last visit before March 2015.
Statistical analysis
The presence of postsurgical soft tissue reaction during
follow-up in the two groups was analysed using Kaplan–
Meier curves. A log-rank test was performed to determine
differences in soft tissue reaction between the cohorts. The
level of significance applied was p = 0.05. All analyses
were performed using Statistical Package for Social Sci-
ences (IBM SPSS Statistics for Windows, Armonk, NY;
IBM Corp), version 20.0.
Results
Patients
A total of 202 patients and 211 implants could be included in
the cohort in the period from 1 January 2010 until 31 January
2014. SurgeonA placed the implants consistently outside the
line of incision and surgeon B placed the implants consis-
tently inside the line of incision. Three exceptions were
retrieved, in which the purpose always was to place the
implant inside the line of incision. However, after closure,
due to anatomical variation, it turned out the implant was
outside the line of incision. From all implants, 96 BAHIs
were placed outside the line of incision. Themean age in this
group was 55 years (range 18–85 years, SD ± 16) and the
median follow-up was 653 days per implant [interquartile
range (IQR) 337–1058 days]. There were 115 implants
placed inside the line of incision. Themean agewas 53 years
(range 18–83 years, SD ± 15) and the median follow-up
was 548 days per implant (IQR 353–1046 days). A number
of 81 of 202 patients participated in a clinical trial with a
more extensive (standard) follow-up protocol, similarly
distributed over the two different cohorts. All the baseline
characteristics of the patient population are shown in
Table 1. No significant differences in these baseline char-
acteristics between both groups were noticed. The use of
longer abutments was equally distributed between the study
groups, however, slightlymore previous generation implants
and abutments were used in the inside group. In Table 2 the
other surgical characteristics are summarised. The length of
all implants was 4 mm.
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Implant loss and revision surgery
Three implants were lost during complete follow-up
(1.4 %). All these implants were placed outside the line of
incision. One implant was lost 3 days after surgery. The
medical chart reported a poor quality of the temporal bone.
The other implants were lost after 46 days and after more
than 3 years (this patient suffered from recurrent infections
with peri-implantitis in the period prior to implant loss).
During the complete follow-up, in 18 of 211 implants,
one or multiple revisions were performed (8.5 %). In the
group with the implant outside the line of incision, revision
Table 1 Background
characteristics of the patient
population
Inside Outside
n % n %
Total patients 111 100 92 100
Total implants 115 96
Gender
Male 43 38.7 38 41.3
Female 68 61.3 54 58.7
Age at surgery
Mean (years) [±SD] 53 [±15] 55 [±16]
Range (years) 18–83 18–85
Aetiology of hearing loss
Acquired conductive/mixed hearing loss 74 66.7 73 79.3
Congenital conductive hearing loss 9 8.1 5 5.4
Single-sided deafness 28 25.2 14 15.2
Comorbidity factors
Mental retardation 5 4.5 3 3.3
Diabetes mellitus 10 8.9 7 7.6
Dermatological disease 10 8.9 9 9.8
Table 2 Surgical
characteristics of the patient
population
Inside Outside
n % n %
Total implants 115 100 96 100
Follow-up
Median (days) 548 653
Interquartile range (days) 353–1046 337–1058
Loading time
Mean (weeks) [±SD] 5.5 [±3.2] 5.4 [±3.0]
Type of implant-abutment
Previous generation Cochlear 14 12.2 5 5.2
BIA210 9 7.8 3 3.1
BIA300 36 31.3 35 36.5
BIA400 0 0 1 1.0
Ponto Regular 32 27.8 37 38.5
Ponto Wide 24 20.9 15 15.6
Abutment length
5.5 mm 22 19.1 7 7.3
6 mm 74 64.3 72 75.0
8.5 mm 1 0.9 0 0
9 mm 14 12.2 10 10.4
10 mm 0 0 1 1.0
Unknown 4 3.5 6 6.3
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surgery was performed in 5 of 96 implants (5.2 %). In the
set of implants placed inside the line of incision, revision
surgery was undertaken for 13 of 115 implants (11.3 %).
This difference in performed revision surgery between both
groups, as calculated with a log-rank test, was not signifi-
cant (p = 0.129). An overview of the revision surgery and
other therapeutic interventions in both groups is given in
Table 3.
Soft tissue reaction
The outcome was divided in the presence of a soft tissue
reaction (i.e. Holgers grade 1 or higher) and the presence of
an adverse soft tissue reaction (i.e. Holgers grade 2 or
higher). In 6.7 % of the follow-up contacts a notation of a
soft tissue reaction was available but no Holgers classifi-
cation was given, and in 3.7 % of the follow-up contacts a
description about the tissue surrounding the implant was
missing. A soft tissue reaction Holgers C1 was noticed in
47 implants (49.0 %) when the implant was placed outside
the line of incision compared to 70 implants (60.9 %)
which were placed inside the line of incision. The median
time until the first soft tissue reaction was 90 days (IQR
21–366 days) and 95 days (IQR 44–344 days),
respectively.
An adverse soft tissue reaction, Holgers grade C2, was
registered in 17 implants (17.7 %) when the implant was
placed outside the line of incision. In the group of implants
placed inside the line of incision, 20 implants (17.4 %)
presented with a Holgers C2. The median time until the
first adverse soft tissue reaction was 363 days (IQR
127–675 days) and 183 days (IQR 112–370 days),
respectively.
For both outcome measures a survival curve was cal-
culated by the Kaplan–Meier method; the Kaplan–Meier
curves and survival tables are shown in Figs. 2 and 3 and
Tables 4 and 5. The Kaplan–Meier curves show the prob-
ability of surviving, i.e. not encountering an (adverse) soft
tissue reaction, in a given length of time. The corre-
sponding survival tables provide additional information
about the cumulative events (CE), remaining cases (RC)
and cumulative proportion surviving (CPS) at given points
in the time during the follow-up. In these tables, the
cumulative events are defined as the number of implants
with (adverse) soft tissue reactions and the remaining cases
are the implants still in the follow-up without soft tissue
problems. The term cumulative proportion surviving can be
explained as a statistical representation of the proportion of
implants that have not reached the terminal event (i.e. skin
reaction) by the end of an interval. A log-rank test was
Table 3 Overview of
therapeutic interventions and
revision surgery during follow-
up
Inside Outside
n % n %
Number of local treatments
0 62 53.9 55 57.3
1 39 33.9 30 31.3
2 9 7.8 7 7.3
3 4 3.5 2 2.1
4 1 0.9 1 1.0
5 0 0 0 0
6 0 0 1 1.0
Number of systemic treatments
0 112 97.4 94 97.9
1 3 2.6 1 1.0
2 0 0 1 1.0
Revision surgerya
Soft tissue reduction 4 3
Secondary higher abutment 7 2
New implant 1 0
Both soft tissue reduction ? higher abutment 3 0
Both higher abutment ? new implant 1b 0
a Regarding the group with implants placed inside the line of incision: in three implants was two times
revision surgery performed, numbers shown indicate how often the procedure is performed
b During this revision procedure was the implant accidently lost while removing the previous abutment, so
both a higher abutment and a new implant were placed
Eur Arch Otorhinolaryngol (2016) 273:3713–3722 3717
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Fig. 2 Kaplan–Meier analysis:
soft tissue reaction Holgers C1
Fig. 3 Kaplan–Meier analysis:
adverse soft tissue reaction
Holgers C2
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executed to compare the survival curves of the two surgical
techniques. No significant differences were found between
the two groups for both the presence of soft tissue reactions
(p = 0.322) and a Holgers score of 2 or higher (p = 0.951)
during the follow-up.
Discussion
In this historical cohort study, 202 patients and 211
implants were studied with a total median follow-up time
of 555 days (IQR 351–1055). No significant differences
were found in the presence of postsurgical soft tissue
reactions or adverse soft tissue reactions between the two
cohorts, i.e. the placement of the percutaneous BAHI inside
or outside the line of incision.
As stated in the ‘‘Introduction’’, of all possible tech-
niques for placement of bone-anchored hearing implants
the linear incision technique is most popular because of its
favourable outcomes [13, 14]. Nevertheless, little is known
about the placement of the BAHI inside or outside the line
of incision, as both techniques are described and used. To
our knowledge, this is the first large-scale retrospective
study focusing on this particular step in the procedure of
implantation with the linear incision technique. Although
this retrospective study design and a setting in a tertiary
referral centre made it possible to include a relatively large
cohort of patients, it might be possible both groups lack
patients to detect somewhat smaller differences in the
presence of skin reactions.
In addition to the large cohort investigated in this study,
other strengths are the representative characteristics of our
sample. The rates of implant loss and revision surgery were
similar or slightly better compared with previous studies in
our centre [7, 20] or according to other studies [8, 13]. In
addition, no differences in baseline characteristics between
both groups were noticed.
Despite the fact that the follow-up contacts in the
medical charts had few missing data (3.7 %), the retro-
spective study design could be considered as a limitation of
this study. All data were obtained from our Bone Implant
database and patients medical charts and during this case
analysis, as described in the ‘‘Methods’’, assumptions were
made. First of all, in 6.7 % of the follow-up contacts, only
a description of the skin surrounding the titanium skin-
penetrating implant was documented without a Holgers
classification. In these cases, any notation of signs of
inflammation was registered as the presence of a soft tissue
reaction (i.e. Holgers grade 1 or higher). If there was no
notation of inflammation of the skin, it was interpreted as
the absence of a soft tissue reaction (i.e. Holgers grade 0).
Moreover, it was chosen to exclude consultation by tele-
phone, because these soft tissue reactions could not be
objectified and graded by trained professionals. However,
this decision could cause an underestimation of the amount
of postoperative skin problems. Furthermore, for some of
the background characteristics frequently incomplete
patient information was available in the charts.
Another limitation could be confounding caused by the
two surgeons performing in principle only one of the sur-
gical techniques for implantation (surgeon A: implant
outside the line of incision, surgeon B: implant inside the
line of incision). Although the other steps in the surgical
procedure were similar, it is inevitable some minor dif-
ferences in the surgical and peri-operative approaches are
present, possibly influencing the outcomes. Ideally, both
surgeons should have been performing both the surgical
techniques to prevent this confounding factor. This is a
limitation of the study design. Moreover, slightly more
previous generation implants and abutments were present
in the group with implants placed inside the line of inci-
sion. This also might have been a confounding factor,
because ongoing developments in the field of implants and
abutments have led to less skin reactions in the current
types [21].
Finally, the duration of the follow-up of the implants
was limited with a median of 653 days (IQR
337–1058 days) and 548 days (IQR 353–1046 days) for
implants placed outside and inside the line of incision,
respectively . Nevertheless, based on our hypothesis it was
expected that differences between both techniques would
be seen shortly postoperative, so this relative restricted
difference in follow-up was not considered as a serious
limitation. In the context of follow-up contacts, it was
noticed that 48 patients, slightly unequally divided between
the two groups, had less than three follow-up contacts. This
can only partially be explained by the group of patients
which had received the BAHI most recently. Other reasons
might be that patients did not encounter any problems
postoperatively, completed their follow-up at another clinic
or did not use the BAHA because of (skin) problems. This
could influence the outcome positively or negatively.
Future research should be focusing on the sustainability
of these already clinically favourable results with new
generation implants and abutments. This is also relevant in
the context of modifications in the linear incision, for
example the linear incision technique with tissue preser-
vation. It has been advocated that this less invasive
approach results in faster healing, better aesthetic appear-
ance and less soft tissue problems. Due to the development
of longer abutments, it has been possible to study this
proposed modification in the clinical practise. Several
recent prospective studies have already shown promising
outcomes compared to the traditional technique [22–26]. It
has been suggested in the tissue preservation technique to
preferably place the implant outside the line of incision. In
3720 Eur Arch Otorhinolaryngol (2016) 273:3713–3722
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the light of the outcomes of this evaluation, also in tissue
preservation the implant position might not be influencing
the outcomes. Additionally, since these implants are also
an important hearing rehabilitation option in children, it
would be interesting to find out if our results are also valid
for this population, especially because implantation in
children is more vulnerable to skin problems postopera-
tively compared to adults [7, 8, 11].
In conclusion, no significant difference was found in the
presence of soft tissue reactions and adverse soft tissue
reaction (i.e. Holgers grade 2 or higher) between the
placement of the BAHI inside or outside the line of inci-
sion. In the procedure of the linear incision technique used
in titanium percutaneous osseointegrated hearing implants
for bone conduction hearing, both placing the implant
inside and outside the line of incision can be used
depending on the surgeons’ experience and preferences. In
the area of ongoing developments in the surgical proce-
dure, with the goal to further minimise skin problems
postoperatively, this study contributes to the knowledge
that is available to date.
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